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LETTERS TO THE EDITOR
The danger of studying human chorionic gonadotrophin action or
expression in animal models
Sir - I have read with interest the papers on the 'Protective
effects of chorionic gonadotrophin on DMBA induced mam-
mary carcinogenesis' published in the August 1990 edition of
the British Journal of Cancer (Russo, I.H., Koszalka, M.,
Gimotty, P. & Russo, J. 62: 243-247). Under certain circum-
stances, pregnancy is found to be protective against carcino-
genic induction of mammary tumours in the Sprague-Dawley
virgin rat model used and developed, by the authors. The
proposed mechanism is that pregnancy hormones induced
differentiation of the terminal duct structures, present in the
immature animals, which are susceptible to carcinogenic
substances. Tumourigenesis is known to be modulated by
hormones. The exact mechanisms and hormones required for
such responsive tissues varies according to the differentiation
state prevailing. In an attempt to clarify the situation in the
pregnancy model described, the authors have introduced the
most commonly thought ofplacental specific hormone. 'Non-
pathogenic' quantities of a commercial preparation of hCG
were administered to virgin immature Sprague-Dawley rats
after exposure to DMBA. The authors found an approximate
50% reduction in tumour formation. They concluded that
such treatment can still rescue carcinogen exposed mammary
epithelia from malignant transformation.
Though I concur with the conclusion that the protective
effect of CG is probably indirect; the authors consideration
of the possible mechanism of CG action and pregnancy, in
their rat model is fundamentally flawed. Chorionic gonado-
trophin, being a heterodimeric molecule composed of a com-
mon glycoprotein hormone alpha subunit and specific beta
subunit, is not found in rats or any other lower animal
(reviewed by Pierce & Parsons, 1981). The beta-CG gene(s)
has only evolved in primates and equids and by independent
mechanisms (Fiddes & Talmadge, 1984; Leigh & Stewart,
1990).
It arose from the beta-LH gene by duplication and read-
through into the 3' untranslated region, followed by ampli-
fication to form a cluster of beta-CG genes/pseudogenes
flanked by beta-LH (Fiddes & Talmadge, 1984; Graham et
al., 1987). cDNA hybridisation of beta-LH probes with beta-
CG is inevitable. Using the known nucleic acid homology.
LH probes have been used to try and identify an equivalent
beta-CG gene in rats and cattle. Only a single beta-LH gene
could be detected in these species (Tepper & Roberts, 1984;
Virgin et al., 1985). Thus it has been definitively shown that
rats do not posses the CG specific beta-subunit gene. The
authors have been misled by the unsubstantiated study they
quote.
Though CG would appear to be essential in maternal
recognition of primate and equid pregnancy, its presumed
function is achieved in lower animals by quite different
molecules. For lower mammals such as the sheep, cows and
by inference rodents, corpus luteum rescue is achieved by a
trophoblastic protein very similar to mammalian interferon
alpha-2 (Imakawa et al., 1987; Stewart et al., 1990; Chard,
1989). The influence of trophoblastic interferon in pregnant
rats treated with DMBA must therefore be considered. How-
ever, the authors results would suggest that the protected
effects described are a result of hCG stimulation of the
rodent gonadal LH receptors. Thus, in agreement with the
papers concluding remarks, oestrogen and progesterone
steroid hormones are most likely to be the protective (differ-
entiation) signals active in this model.
R.K. Iles
Joint Academic Departments of Obstetrics,
Gynaecology and Reproductive Physiology,
St. Bartholomew's Hospital Medical College,
London, UK.
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